Company Lookup
عربي
 
 

Market News

This Month News

This Month News

send to a friend by email

JPH reports net income of $1.19 million in Q1 2018

2018-04-30

According to the financial statements of Jerusalem Pharmaceuticals JPH for the quarter of 2018, Net profit after tax of the period reached 1,188,800 USD Compared with Net profit after tax 1,605,998 USD for 2017, a net decrease in profit of 25.98%.Total assets of the company reached 62,652,758 USD compared with total assets of 61,625,755 USD at the end of year 2017, a net increase of 1.67%.Total liabilities of the company reached 12,109,427 USD compared with total liabilities of 12,237,751 USD at the end of year 2017, a net decrease of 1.04%. Net ownership equity of the company reached 50,543,331 USD (Including Non-Controlling Interests of 842,333 USD) compared with total owner equity of 49,388,004 USD (Including Non-Controlling Interests of 851,077 USD) at the end of year 2017, a net increase of 2.34%.

 


 

2024-04-15
TPIC proposes distributing 5% stocks dividends for the year 2023

2024-04-14
PIBC recommends distributing 2.5641% stocks dividends for the year 2023

2024-04-14
ABRAJ recommends converting the company from public shareholding to private shareholding

2024-04-14
NCI recommends distributing 12% cash dividends for the year 2023

2024-04-04
TRUST approves distributing 10% cash dividends for the year 2023

2024-04-04
Al-Quds Index stands-still with the start of April

2024-04-03
TIC approves distributing 15% cash dividends for the year 2023

2024-04-01
NSC recommends distributing 7% stocks dividends for the year 2023

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013
PHP Notice: Undefined index: archive in C:\Inetpub\wwwroot\sahem\menu.php on line 403